TSXV - Delayed Quote CAD

Theralase Technologies Inc. (TLT.V)

0.1650 0.0000 (0.00%)
At close: April 24 at 1:43 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,070.3070
1,070.3070
1,138.5690
780.6410
929.1220
Cost of Revenue
508.1730
508.1730
510.3950
470.6980
659.4420
Gross Profit
562.1340
562.1340
628.1740
309.9430
269.6800
Operating Expense
5,156.4000
5,156.4000
5,859.7180
4,851.4860
5,966.3860
Operating Income
-4,594.2660
-4,594.2660
-5,231.5440
-4,541.5430
-5,696.7060
Net Non Operating Interest Income Expense
19.4050
19.4050
9.4120
17.3200
94.0060
Other Income Expense
3.9810
3.9810
-13.1700
113.1620
4.1600
Pretax Income
-4,570.8800
-4,570.8800
-5,235.3020
-4,411.0610
-5,598.5400
Net Income Common Stockholders
-4,570.8790
-4,570.8790
-5,235.3020
-4,411.0610
-5,598.5400
Diluted NI Available to Com Stockholders
-4,570.8790
-4,570.8790
-5,235.3020
-4,411.0610
-5,598.5400
Basic EPS
-0.02
--
-0.03
-0.02
-0.03
Diluted EPS
-0.02
--
-0.03
-0.02
-0.03
Basic Average Shares
219,968.3790
--
207,924.3130
204,275.8750
204,275.8750
Diluted Average Shares
219,968.3790
--
207,924.3130
204,275.8750
204,275.8750
Rent Expense Supplemental
41.2160
41.2160
47.0970
39.5490
39.9670
Total Expenses
5,664.5730
5,664.5730
6,370.1130
5,322.1840
6,625.8280
Net Income from Continuing & Discontinued Operation
-4,570.8790
-4,570.8790
-5,235.3020
-4,411.0610
-5,598.5400
Normalized Income
-4,574.8600
-4,574.8600
-5,222.1320
-4,524.2230
-5,602.7000
Interest Income
49.8110
49.8110
30.6610
22.6620
103.6860
Interest Expense
30.4060
30.4060
21.2490
5.3420
9.6800
Net Interest Income
19.4050
19.4050
9.4120
17.3200
94.0060
EBIT
-4,540.4740
-4,540.4740
-5,214.0530
-4,405.7190
-5,588.8600
EBITDA
-4,254.3500
-4,254.3500
-4,900.8220
-4,129.5690
-5,316.5810
Reconciled Cost of Revenue
269.3110
269.3110
246.0220
271.7060
482.7780
Reconciled Depreciation
286.1240
286.1240
313.2310
276.1500
272.2790
Net Income from Continuing Operation Net Minority Interest
-4,570.8790
-4,570.8790
-5,235.3020
-4,411.0610
-5,598.5400
Total Unusual Items Excluding Goodwill
3.9810
3.9810
-13.1700
113.1620
4.1600
Total Unusual Items
3.9810
3.9810
-13.1700
113.1620
4.1600
Normalized EBITDA
-4,258.3310
-4,258.3310
-4,887.6520
-4,242.7310
-5,320.7410
12/31/2020 - 2/13/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VPT.V VentriPoint Diagnostics Ltd.
0.2100
-4.55%
 
QTNA.F Titan Medical Inc.
0.0305
-11.59%
 
TEST-H.V FluroTech Ltd.
0.0050
0.00%
 
HTL.TO Hamilton Thorne Ltd.
1.3600
0.00%
 
XTNT Xtant Medical Holdings, Inc.
0.8900
-2.09%
 
MDX.V MedX Health Corp
0.0900
-5.26%
 
TMCI Treace Medical Concepts, Inc.
10.67
-1.75%
 
BLO.CN Cannabix Technologies Inc.
0.4450
+12.66%
 
APYX Apyx Medical Corporation
1.5000
+13.64%
 
THRM.V Therma Bright Inc.
0.0100
0.00%